ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SCLXW Scilex Holding Company

0.239999
-0.0175 (-6.80%)
Jan 17 2025 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,161
Bid Price 0.1066
Ask Price 0.48
News (4)
Company Name Stock Ticker Symbol Market Type
Scilex Holding Company SCLXW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
-0.0175 -6.80% 0.239999 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.27 0.239999 0.27 0.239999 0.2575
Trades Volume VWAP Dollar Volume Avg Volume
52 5,161  0.2399999  1,239 -
Last Trade Time Type Quantity Stock Price Currency
16:00:00 300  0.24 USD

Scilex Holding Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
40.16M 155.94M - 46.74M -114.33M -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Scilex

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SCLXW Message Board. Create One! See More Posts on SCLXW Message Board See More Message Board Posts

SCLXW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5.

SCLXW -

What is the current Scilex Holding Company share price?
The current share price of Scilex Holding Company is $ 0.239999
How many Scilex Holding Company shares are in issue?
Scilex Holding Company has 155,943,000 shares in issue
What is the market cap of Scilex Holding Company?
The market capitalisation of Scilex Holding Company is USD 40.16M
What is the 1 year trading range for Scilex Holding Company share price?
Scilex Holding Company has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Scilex Holding Company?
The price to earnings ratio of Scilex Holding Company is -0.6
What is the cash to sales ratio of Scilex Holding Company?
The cash to sales ratio of Scilex Holding Company is 1.47
What is the reporting currency for Scilex Holding Company?
Scilex Holding Company reports financial results in USD
What is the latest annual turnover for Scilex Holding Company?
The latest annual turnover of Scilex Holding Company is USD 46.74M
What is the latest annual profit for Scilex Holding Company?
The latest annual profit of Scilex Holding Company is USD -114.33M
What is the registered address of Scilex Holding Company?
The registered address for Scilex Holding Company is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Scilex Holding Company website address?
The website address for Scilex Holding Company is www.scilexholding.com
Which industry sector does Scilex Holding Company operate in?
Scilex Holding Company operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector